agreement call alkerm provid $ 4.5 million
research develop fund cortex two-year
period compani said alkerm ad cortex could
receiv much $ 10 million payment product
candid proceed trial
alkerm also purchas 750,000 cortex common share
$ 1.5 million receiv warrant purchas addit
two million cortex share one million share $ 3 share
one million share $ 7.50 share total
$ 10.5 million warrant exercis
agreement also give alkerm exclus world-wid
right make market product result
collabor cortex would receiv royalti product
sale
collabor intend combin drug candid
develop cortex techniqu develop alkerm
get drug cross blood-brain barrier network
tissu block molecul enter brain
blood cortex drug involv consist three
class substanc block action calpain
enzym thought destroy nerv cell number brain
disord alkerm said
